HEXO stock is in a questionable position at present. Quebec’s cannabis giant released Q3 results in mid-June and showed unexpected weaknesses in its performance. Also adding to the skepticism, two prominent analysts downgraded the stock.
It’s an important time for the industry; the legal cannabis derivatives market is expected to launch across Canada in October, but sales won’t begin until December.
Currently, HEXO Corp (TSX:HEXO) (NYSE:HEXO) is selling for $5.38 USD on the NYSE American, up 1.13% at the time of writing.
HEXO StockBefore June, these shares appeared to be on ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.